nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Cytochrome P450 3A4 Inducers—Topiramate—migraine	0.597	1	CiPCiCtD
Aprepitant—CYP3A7—Propranolol—migraine	0.0196	0.0755	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Propranolol—migraine	0.0196	0.0755	CbGbCtD
Aprepitant—CYP3A5—Propranolol—migraine	0.0147	0.0567	CbGbCtD
Aprepitant—CYP3A7—Verapamil—migraine	0.0134	0.0518	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Verapamil—migraine	0.0134	0.0518	CbGbCtD
Aprepitant—CYP2C19—Timolol—migraine	0.0133	0.0513	CbGbCtD
Aprepitant—CYP3A5—Amitriptyline—migraine	0.0127	0.049	CbGbCtD
Aprepitant—CYP2C19—Propranolol—migraine	0.0119	0.0457	CbGbCtD
Aprepitant—CYP3A5—Valproic Acid—migraine	0.0116	0.0447	CbGbCtD
Aprepitant—CYP1A2—Propranolol—migraine	0.0109	0.0422	CbGbCtD
Aprepitant—CYP2C19—Amitriptyline—migraine	0.0103	0.0395	CbGbCtD
Aprepitant—CYP3A5—Verapamil—migraine	0.0101	0.0389	CbGbCtD
Aprepitant—CYP1A2—Amitriptyline—migraine	0.00946	0.0365	CbGbCtD
Aprepitant—CYP2C19—Valproic Acid—migraine	0.00934	0.036	CbGbCtD
Aprepitant—CYP1A2—Valproic Acid—migraine	0.00862	0.0332	CbGbCtD
Aprepitant—CYP2C9—Amitriptyline—migraine	0.00852	0.0329	CbGbCtD
Aprepitant—CYP2C19—Topiramate—migraine	0.00843	0.0325	CbGbCtD
Aprepitant—CYP2C19—Verapamil—migraine	0.00813	0.0314	CbGbCtD
Aprepitant—CYP2C9—Valproic Acid—migraine	0.00777	0.03	CbGbCtD
Aprepitant—CYP1A2—Verapamil—migraine	0.00751	0.0289	CbGbCtD
Aprepitant—TACR3—Tachykinin receptors bind tachykinins—TAC1—migraine	0.00731	0.181	CbGpPWpGaD
Aprepitant—CYP2C9—Verapamil—migraine	0.00676	0.0261	CbGbCtD
Aprepitant—CYP3A4—Propranolol—migraine	0.00573	0.0221	CbGbCtD
Aprepitant—TACR1—trigeminal nerve—migraine	0.00498	0.207	CbGeAlD
Aprepitant—CYP3A4—Amitriptyline—migraine	0.00496	0.0191	CbGbCtD
Aprepitant—CYP3A4—Valproic Acid—migraine	0.00452	0.0174	CbGbCtD
Aprepitant—CYP3A4—Topiramate—migraine	0.00408	0.0157	CbGbCtD
Aprepitant—CYP3A4—Verapamil—migraine	0.00393	0.0152	CbGbCtD
Aprepitant—TACR1—Tachykinin receptors bind tachykinins—TAC1—migraine	0.00357	0.0883	CbGpPWpGaD
Aprepitant—TACR1—cranial nerve—migraine	0.00355	0.148	CbGeAlD
Aprepitant—TACR1—peripheral nervous system—migraine	0.00233	0.0971	CbGeAlD
Aprepitant—TACR3—brainstem—migraine	0.00202	0.0839	CbGeAlD
Aprepitant—TACR1—nerve—migraine	0.00182	0.0757	CbGeAlD
Aprepitant—TACR3—cardiovascular system—migraine	0.00165	0.0685	CbGeAlD
Aprepitant—TACR3—head—migraine	0.00111	0.0464	CbGeAlD
Aprepitant—TACR3—nervous system—migraine	0.00106	0.044	CbGeAlD
Aprepitant—TACR3—central nervous system—migraine	0.00102	0.0423	CbGeAlD
Aprepitant—TACR3—cerebellum—migraine	0.000994	0.0414	CbGeAlD
Aprepitant—TACR3—Peptide GPCRs—EDNRA—migraine	0.000808	0.02	CbGpPWpGaD
Aprepitant—TACR3—brain—migraine	0.000808	0.0336	CbGeAlD
Aprepitant—TACR1—brainstem—migraine	0.000781	0.0325	CbGeAlD
Aprepitant—TACR3—G alpha (q) signalling events—HTR2B—migraine	0.000653	0.0161	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000584	0.0144	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000572	0.0141	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CALCRL—migraine	0.000488	0.0121	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—RAMP1—migraine	0.000488	0.0121	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—HTR3A—migraine	0.000487	0.012	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000465	0.0115	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000433	0.0107	CbGpPWpGaD
Aprepitant—TACR1—head—migraine	0.000432	0.018	CbGeAlD
Aprepitant—TACR1—nervous system—migraine	0.000409	0.017	CbGeAlD
Aprepitant—TACR3—G alpha (q) signalling events—TAC1—migraine	0.000403	0.00997	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—NPS—migraine	0.000403	0.00997	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—NPS—migraine	0.000398	0.00985	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—TAC1—migraine	0.000398	0.00985	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—HTR2C—migraine	0.000396	0.00978	CbGpPWpGaD
Aprepitant—TACR1—Peptide GPCRs—EDNRA—migraine	0.000395	0.00975	CbGpPWpGaD
Aprepitant—TACR1—central nervous system—migraine	0.000394	0.0164	CbGeAlD
Aprepitant—TACR3—G alpha (q) signalling events—EDNRA—migraine	0.000385	0.00951	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—EDNRA—migraine	0.00038	0.00939	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000361	0.00892	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000361	0.00892	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—HTR1D—migraine	0.000354	0.00876	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000354	0.00875	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000344	0.00851	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—HTR2B—migraine	0.000329	0.00814	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—HTR2B—migraine	0.000319	0.00788	CbGpPWpGaD
Aprepitant—TACR1—brain—migraine	0.000313	0.013	CbGeAlD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000285	0.00705	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000282	0.00697	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CALCRL—migraine	0.000276	0.00681	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—RAMP1—migraine	0.000276	0.00681	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000271	0.00671	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000267	0.0066	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000267	0.0066	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000262	0.00648	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000255	0.0063	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CALCRL—migraine	0.00025	0.00618	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—RAMP1—migraine	0.00025	0.00618	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—HTR2A—migraine	0.000243	0.006	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—RAMP1—migraine	0.000238	0.00589	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CALCRL—migraine	0.000238	0.00589	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—HTR1A—migraine	0.000231	0.00572	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00023	0.00567	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—TAC1—migraine	0.000228	0.00563	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000227	0.00562	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000223	0.00552	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000217	0.00537	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—HTR1B—migraine	0.000215	0.00531	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000211	0.00522	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—HTR1A—migraine	0.000207	0.00511	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—NPS—migraine	0.000203	0.00503	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—TAC1—migraine	0.000203	0.00503	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—BDNF—migraine	0.000203	0.00501	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—HTR1D—migraine	0.0002	0.00495	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—HTR2C—migraine	0.0002	0.00493	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—TAC1—migraine	0.000197	0.00487	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—NPS—migraine	0.000197	0.00487	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—NPS—migraine	0.000195	0.00481	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—TAC1—migraine	0.000195	0.00481	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—EDNRA—migraine	0.000194	0.0048	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—HTR2C—migraine	0.000193	0.00478	CbGpPWpGaD
Aprepitant—CYP2C9—cardiovascular system—migraine	0.000189	0.00785	CbGeAlD
Aprepitant—TACR1—G alpha (q) signalling events—EDNRA—migraine	0.000188	0.00465	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CALCA—migraine	0.000187	0.00462	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—HTR2B—migraine	0.000186	0.0046	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—EDNRA—migraine	0.000186	0.00459	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—HTR1D—migraine	0.000182	0.00449	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000176	0.00436	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000176	0.00436	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—HTR7—migraine	0.000175	0.00432	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—HTR1D—migraine	0.000173	0.00428	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000173	0.00427	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—HTR2B—migraine	0.000169	0.00418	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000168	0.00416	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—BDNF—migraine	0.000162	0.00401	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—HTR2B—migraine	0.000161	0.00398	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000161	0.00397	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—RAMP1—migraine	0.000148	0.00365	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CALCRL—migraine	0.000148	0.00365	CbGpPWpGaD
Aprepitant—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000139	0.00343	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000138	0.0034	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—FOS—migraine	0.000137	0.00339	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—HTR2A—migraine	0.000137	0.00339	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—RAMP1—migraine	0.000135	0.00333	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CALCRL—migraine	0.000135	0.00333	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000133	0.00327	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00013	0.00323	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00013	0.00323	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000128	0.00316	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000124	0.00308	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—HTR2A—migraine	0.000122	0.00303	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CALCRL—migraine	0.000122	0.00302	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—RAMP1—migraine	0.000122	0.00302	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—HTR1B—migraine	0.000121	0.003	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—HTR2A—migraine	0.000119	0.00293	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—HTR1A—migraine	0.000117	0.00289	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—TAC1—migraine	0.000115	0.00284	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—NPS—migraine	0.000115	0.00284	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—HTR2C—migraine	0.000113	0.00279	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000112	0.00277	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—HTR1B—migraine	0.00011	0.00272	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—EDNRA—migraine	0.00011	0.00271	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HTR1D—migraine	0.000107	0.00265	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—HTR1A—migraine	0.000106	0.00262	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000106	0.00262	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CALCA—migraine	0.000106	0.00261	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—HTR1B—migraine	0.000105	0.00259	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TAC1—migraine	0.000104	0.00258	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—NPS—migraine	0.000104	0.00258	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—HTR2C—migraine	0.000102	0.00253	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—HTR1A—migraine	0.000101	0.00249	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HTR2B—migraine	9.98e-05	0.00247	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—EDNRA—migraine	9.96e-05	0.00246	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—TAC1—migraine	9.94e-05	0.00246	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—NPS—migraine	9.94e-05	0.00246	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—HTR7—migraine	9.88e-05	0.00244	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—HTR1D—migraine	9.78e-05	0.00242	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—HTR2C—migraine	9.75e-05	0.00241	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CALCA—migraine	9.59e-05	0.00237	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—EDNRA—migraine	9.48e-05	0.00234	CbGpPWpGaD
Aprepitant—CYP3A4—nervous system—migraine	9.24e-05	0.00384	CbGeAlD
Aprepitant—TACR1—GPCR ligand binding—CALCA—migraine	9.13e-05	0.00226	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—HTR2B—migraine	9.09e-05	0.00225	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—HTR7—migraine	8.97e-05	0.00222	CbGpPWpGaD
Aprepitant—CYP3A4—central nervous system—migraine	8.89e-05	0.0037	CbGeAlD
Aprepitant—TACR1—Signaling by GPCR—HTR1D—migraine	8.88e-05	0.00219	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—LRP1—migraine	8.79e-05	0.00217	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—HTR7—migraine	8.54e-05	0.00211	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—HTR2B—migraine	8.25e-05	0.00204	CbGpPWpGaD
Aprepitant—Arthralgia—Valproic Acid—migraine	8.19e-05	0.00103	CcSEcCtD
Aprepitant—Chest pain—Valproic Acid—migraine	8.19e-05	0.00103	CcSEcCtD
Aprepitant—Myalgia—Valproic Acid—migraine	8.19e-05	0.00103	CcSEcCtD
Aprepitant—Haematuria—Topiramate—migraine	8.19e-05	0.00103	CcSEcCtD
Aprepitant—Anxiety—Valproic Acid—migraine	8.16e-05	0.00103	CcSEcCtD
Aprepitant—Hypersensitivity—Verapamil—migraine	8.16e-05	0.00103	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	8.14e-05	0.00102	CcSEcCtD
Aprepitant—Alopecia—Gabapentin—migraine	8.1e-05	0.00102	CcSEcCtD
Aprepitant—Discomfort—Valproic Acid—migraine	8.09e-05	0.00102	CcSEcCtD
Aprepitant—Mental disorder—Gabapentin—migraine	8.03e-05	0.00101	CcSEcCtD
Aprepitant—Dry mouth—Valproic Acid—migraine	8.01e-05	0.00101	CcSEcCtD
Aprepitant—Malnutrition—Gabapentin—migraine	7.98e-05	0.001	CcSEcCtD
Aprepitant—Erythema—Gabapentin—migraine	7.98e-05	0.001	CcSEcCtD
Aprepitant—Dizziness—Propranolol—migraine	7.96e-05	0.001	CcSEcCtD
Aprepitant—Asthenia—Verapamil—migraine	7.95e-05	0.000998	CcSEcCtD
Aprepitant—Confusional state—Valproic Acid—migraine	7.92e-05	0.000995	CcSEcCtD
Aprepitant—Flatulence—Gabapentin—migraine	7.86e-05	0.000987	CcSEcCtD
Aprepitant—Oedema—Valproic Acid—migraine	7.85e-05	0.000987	CcSEcCtD
Aprepitant—Anaphylactic shock—Valproic Acid—migraine	7.85e-05	0.000987	CcSEcCtD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	7.85e-05	0.00194	CbGpPWpGaD
Aprepitant—Bradycardia—Topiramate—migraine	7.85e-05	0.000986	CcSEcCtD
Aprepitant—Pruritus—Verapamil—migraine	7.84e-05	0.000984	CcSEcCtD
Aprepitant—Angioedema—Timolol—migraine	7.83e-05	0.000983	CcSEcCtD
Aprepitant—Dysgeusia—Gabapentin—migraine	7.81e-05	0.000981	CcSEcCtD
Aprepitant—Infection—Valproic Acid—migraine	7.8e-05	0.00098	CcSEcCtD
Aprepitant—Back pain—Gabapentin—migraine	7.72e-05	0.000969	CcSEcCtD
Aprepitant—Nervous system disorder—Valproic Acid—migraine	7.7e-05	0.000967	CcSEcCtD
Aprepitant—Thrombocytopenia—Valproic Acid—migraine	7.69e-05	0.000966	CcSEcCtD
Aprepitant—Syncope—Timolol—migraine	7.68e-05	0.000965	CcSEcCtD
Aprepitant—Hypoaesthesia—Topiramate—migraine	7.67e-05	0.000964	CcSEcCtD
Aprepitant—Hallucination—Topiramate—migraine	7.67e-05	0.000964	CcSEcCtD
Aprepitant—Muscle spasms—Gabapentin—migraine	7.67e-05	0.000963	CcSEcCtD
Aprepitant—Tachycardia—Valproic Acid—migraine	7.66e-05	0.000963	CcSEcCtD
Aprepitant—Vomiting—Propranolol—migraine	7.66e-05	0.000962	CcSEcCtD
Aprepitant—Pharyngitis—Topiramate—migraine	7.65e-05	0.000961	CcSEcCtD
Aprepitant—Skin disorder—Valproic Acid—migraine	7.63e-05	0.000958	CcSEcCtD
Aprepitant—Urinary tract disorder—Topiramate—migraine	7.61e-05	0.000956	CcSEcCtD
Aprepitant—Hyperhidrosis—Valproic Acid—migraine	7.59e-05	0.000954	CcSEcCtD
Aprepitant—Rash—Propranolol—migraine	7.59e-05	0.000954	CcSEcCtD
Aprepitant—Dermatitis—Propranolol—migraine	7.58e-05	0.000953	CcSEcCtD
Aprepitant—Diarrhoea—Verapamil—migraine	7.58e-05	0.000952	CcSEcCtD
Aprepitant—Connective tissue disorder—Topiramate—migraine	7.58e-05	0.000952	CcSEcCtD
Aprepitant—Palpitations—Timolol—migraine	7.57e-05	0.000951	CcSEcCtD
Aprepitant—Urethral disorder—Topiramate—migraine	7.56e-05	0.000949	CcSEcCtD
Aprepitant—Loss of consciousness—Timolol—migraine	7.53e-05	0.000946	CcSEcCtD
Aprepitant—Anorexia—Valproic Acid—migraine	7.49e-05	0.00094	CcSEcCtD
Aprepitant—Cough—Timolol—migraine	7.47e-05	0.000939	CcSEcCtD
Aprepitant—Tremor—Gabapentin—migraine	7.47e-05	0.000939	CcSEcCtD
Aprepitant—Ill-defined disorder—Gabapentin—migraine	7.4e-05	0.00093	CcSEcCtD
Aprepitant—Hypertension—Timolol—migraine	7.4e-05	0.000929	CcSEcCtD
Aprepitant—Anaemia—Gabapentin—migraine	7.37e-05	0.000926	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—TNF—migraine	7.37e-05	0.00182	CbGpPWpGaD
Aprepitant—Hypotension—Valproic Acid—migraine	7.34e-05	0.000922	CcSEcCtD
Aprepitant—Dizziness—Verapamil—migraine	7.32e-05	0.00092	CcSEcCtD
Aprepitant—Chest pain—Timolol—migraine	7.29e-05	0.000916	CcSEcCtD
Aprepitant—Arthralgia—Timolol—migraine	7.29e-05	0.000916	CcSEcCtD
Aprepitant—Myalgia—Timolol—migraine	7.29e-05	0.000916	CcSEcCtD
Aprepitant—Erythema multiforme—Topiramate—migraine	7.29e-05	0.000916	CcSEcCtD
Aprepitant—Angioedema—Gabapentin—migraine	7.29e-05	0.000916	CcSEcCtD
Aprepitant—Anxiety—Timolol—migraine	7.27e-05	0.000913	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	7.24e-05	0.00091	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—RAMP1—migraine	7.22e-05	0.00178	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CALCRL—migraine	7.22e-05	0.00178	CbGpPWpGaD
Aprepitant—Discomfort—Timolol—migraine	7.21e-05	0.000905	CcSEcCtD
Aprepitant—Eye disorder—Topiramate—migraine	7.2e-05	0.000905	CcSEcCtD
Aprepitant—Malaise—Gabapentin—migraine	7.19e-05	0.000904	CcSEcCtD
Aprepitant—Tinnitus—Topiramate—migraine	7.19e-05	0.000903	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Valproic Acid—migraine	7.15e-05	0.000899	CcSEcCtD
Aprepitant—Flushing—Topiramate—migraine	7.15e-05	0.000899	CcSEcCtD
Aprepitant—Cardiac disorder—Topiramate—migraine	7.15e-05	0.000899	CcSEcCtD
Aprepitant—Syncope—Gabapentin—migraine	7.15e-05	0.000899	CcSEcCtD
Aprepitant—Nausea—Propranolol—migraine	7.15e-05	0.000898	CcSEcCtD
Aprepitant—Dry mouth—Timolol—migraine	7.13e-05	0.000896	CcSEcCtD
Aprepitant—Insomnia—Valproic Acid—migraine	7.1e-05	0.000892	CcSEcCtD
Aprepitant—Paraesthesia—Valproic Acid—migraine	7.05e-05	0.000886	CcSEcCtD
Aprepitant—Palpitations—Gabapentin—migraine	7.05e-05	0.000886	CcSEcCtD
Aprepitant—Confusional state—Timolol—migraine	7.05e-05	0.000886	CcSEcCtD
Aprepitant—Vomiting—Verapamil—migraine	7.04e-05	0.000885	CcSEcCtD
Aprepitant—Loss of consciousness—Gabapentin—migraine	7.01e-05	0.000881	CcSEcCtD
Aprepitant—Dyspnoea—Valproic Acid—migraine	7e-05	0.00088	CcSEcCtD
Aprepitant—Angiopathy—Topiramate—migraine	6.99e-05	0.000879	CcSEcCtD
Aprepitant—Oedema—Timolol—migraine	6.99e-05	0.000878	CcSEcCtD
Aprepitant—Anaphylactic shock—Timolol—migraine	6.99e-05	0.000878	CcSEcCtD
Aprepitant—Rash—Verapamil—migraine	6.98e-05	0.000877	CcSEcCtD
Aprepitant—Somnolence—Valproic Acid—migraine	6.98e-05	0.000877	CcSEcCtD
Aprepitant—Dermatitis—Verapamil—migraine	6.98e-05	0.000876	CcSEcCtD
Aprepitant—Immune system disorder—Topiramate—migraine	6.96e-05	0.000875	CcSEcCtD
Aprepitant—Cough—Gabapentin—migraine	6.96e-05	0.000874	CcSEcCtD
Aprepitant—Mediastinal disorder—Topiramate—migraine	6.95e-05	0.000873	CcSEcCtD
Aprepitant—Infection—Timolol—migraine	6.95e-05	0.000872	CcSEcCtD
Aprepitant—Headache—Verapamil—migraine	6.94e-05	0.000872	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—HTR2A—migraine	6.92e-05	0.00171	CbGpPWpGaD
Aprepitant—Chills—Topiramate—migraine	6.92e-05	0.000869	CcSEcCtD
Aprepitant—Dyspepsia—Valproic Acid—migraine	6.91e-05	0.000868	CcSEcCtD
Aprepitant—Convulsion—Gabapentin—migraine	6.91e-05	0.000868	CcSEcCtD
Aprepitant—Hypertension—Gabapentin—migraine	6.89e-05	0.000865	CcSEcCtD
Aprepitant—Shock—Timolol—migraine	6.88e-05	0.000864	CcSEcCtD
Aprepitant—Nervous system disorder—Timolol—migraine	6.86e-05	0.000861	CcSEcCtD
Aprepitant—Decreased appetite—Valproic Acid—migraine	6.83e-05	0.000858	CcSEcCtD
Aprepitant—Alopecia—Topiramate—migraine	6.81e-05	0.000856	CcSEcCtD
Aprepitant—Myalgia—Gabapentin—migraine	6.79e-05	0.000853	CcSEcCtD
Aprepitant—Chest pain—Gabapentin—migraine	6.79e-05	0.000853	CcSEcCtD
Aprepitant—Arthralgia—Gabapentin—migraine	6.79e-05	0.000853	CcSEcCtD
Aprepitant—Skin disorder—Timolol—migraine	6.79e-05	0.000853	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Valproic Acid—migraine	6.78e-05	0.000852	CcSEcCtD
Aprepitant—Fatigue—Valproic Acid—migraine	6.77e-05	0.000851	CcSEcCtD
Aprepitant—Anxiety—Gabapentin—migraine	6.77e-05	0.00085	CcSEcCtD
Aprepitant—Hyperhidrosis—Timolol—migraine	6.76e-05	0.000849	CcSEcCtD
Aprepitant—Mental disorder—Topiramate—migraine	6.75e-05	0.000848	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—NOTCH4—migraine	6.74e-05	0.00167	CbGpPWpGaD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	6.74e-05	0.000847	CcSEcCtD
Aprepitant—Pain—Valproic Acid—migraine	6.72e-05	0.000844	CcSEcCtD
Aprepitant—Constipation—Valproic Acid—migraine	6.72e-05	0.000844	CcSEcCtD
Aprepitant—Malnutrition—Topiramate—migraine	6.71e-05	0.000843	CcSEcCtD
Aprepitant—Erythema—Topiramate—migraine	6.71e-05	0.000843	CcSEcCtD
Aprepitant—Discomfort—Gabapentin—migraine	6.71e-05	0.000843	CcSEcCtD
Aprepitant—Anorexia—Timolol—migraine	6.66e-05	0.000837	CcSEcCtD
Aprepitant—Dry mouth—Gabapentin—migraine	6.64e-05	0.000834	CcSEcCtD
Aprepitant—Flatulence—Topiramate—migraine	6.61e-05	0.000831	CcSEcCtD
Aprepitant—Nausea—Verapamil—migraine	6.58e-05	0.000826	CcSEcCtD
Aprepitant—Dysgeusia—Topiramate—migraine	6.57e-05	0.000826	CcSEcCtD
Aprepitant—Confusional state—Gabapentin—migraine	6.56e-05	0.000825	CcSEcCtD
Aprepitant—Hypotension—Timolol—migraine	6.53e-05	0.000821	CcSEcCtD
Aprepitant—Oedema—Gabapentin—migraine	6.51e-05	0.000818	CcSEcCtD
Aprepitant—Anaphylactic shock—Gabapentin—migraine	6.51e-05	0.000818	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—HTR1B—migraine	6.51e-05	0.00161	CbGpPWpGaD
Aprepitant—Back pain—Topiramate—migraine	6.49e-05	0.000815	CcSEcCtD
Aprepitant—Feeling abnormal—Valproic Acid—migraine	6.47e-05	0.000813	CcSEcCtD
Aprepitant—Infection—Gabapentin—migraine	6.47e-05	0.000812	CcSEcCtD
Aprepitant—Muscle spasms—Topiramate—migraine	6.45e-05	0.000811	CcSEcCtD
Aprepitant—Gastrointestinal pain—Valproic Acid—migraine	6.42e-05	0.000807	CcSEcCtD
Aprepitant—Shock—Gabapentin—migraine	6.4e-05	0.000805	CcSEcCtD
Aprepitant—Nervous system disorder—Gabapentin—migraine	6.38e-05	0.000802	CcSEcCtD
Aprepitant—Thrombocytopenia—Gabapentin—migraine	6.37e-05	0.000801	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Timolol—migraine	6.37e-05	0.0008	CcSEcCtD
Aprepitant—Tachycardia—Gabapentin—migraine	6.35e-05	0.000798	CcSEcCtD
Aprepitant—Skin disorder—Gabapentin—migraine	6.32e-05	0.000794	CcSEcCtD
Aprepitant—Insomnia—Timolol—migraine	6.32e-05	0.000794	CcSEcCtD
Aprepitant—Hyperhidrosis—Gabapentin—migraine	6.29e-05	0.000791	CcSEcCtD
Aprepitant—Tremor—Topiramate—migraine	6.29e-05	0.00079	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—HTR2A—migraine	6.28e-05	0.00155	CbGpPWpGaD
Aprepitant—Paraesthesia—Timolol—migraine	6.28e-05	0.000789	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—HTR1A—migraine	6.26e-05	0.00155	CbGpPWpGaD
Aprepitant—Urticaria—Valproic Acid—migraine	6.24e-05	0.000784	CcSEcCtD
Aprepitant—Dyspnoea—Timolol—migraine	6.23e-05	0.000783	CcSEcCtD
Aprepitant—Ill-defined disorder—Topiramate—migraine	6.23e-05	0.000782	CcSEcCtD
Aprepitant—Somnolence—Timolol—migraine	6.21e-05	0.000781	CcSEcCtD
Aprepitant—Abdominal pain—Valproic Acid—migraine	6.21e-05	0.00078	CcSEcCtD
Aprepitant—Body temperature increased—Valproic Acid—migraine	6.21e-05	0.00078	CcSEcCtD
Aprepitant—Anorexia—Gabapentin—migraine	6.21e-05	0.00078	CcSEcCtD
Aprepitant—Anaemia—Topiramate—migraine	6.2e-05	0.000779	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—TAC1—migraine	6.17e-05	0.00152	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PGR—migraine	6.17e-05	0.00152	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NPS—migraine	6.17e-05	0.00152	CbGpPWpGaD
Aprepitant—Dyspepsia—Timolol—migraine	6.15e-05	0.000773	CcSEcCtD
Aprepitant—Hypotension—Gabapentin—migraine	6.08e-05	0.000764	CcSEcCtD
Aprepitant—Decreased appetite—Timolol—migraine	6.08e-05	0.000763	CcSEcCtD
Aprepitant—Malaise—Topiramate—migraine	6.05e-05	0.00076	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—HTR2C—migraine	6.05e-05	0.0015	CbGpPWpGaD
Aprepitant—Gastrointestinal disorder—Timolol—migraine	6.04e-05	0.000758	CcSEcCtD
Aprepitant—Fatigue—Timolol—migraine	6.03e-05	0.000757	CcSEcCtD
Aprepitant—Syncope—Topiramate—migraine	6.02e-05	0.000756	CcSEcCtD
Aprepitant—Pain—Timolol—migraine	5.98e-05	0.000751	CcSEcCtD
Aprepitant—TACR1—GPCR ligand binding—HTR2A—migraine	5.98e-05	0.00148	CbGpPWpGaD
Aprepitant—Musculoskeletal discomfort—Gabapentin—migraine	5.93e-05	0.000745	CcSEcCtD
Aprepitant—Palpitations—Topiramate—migraine	5.93e-05	0.000745	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—HTR1B—migraine	5.92e-05	0.00146	CbGpPWpGaD
Aprepitant—Loss of consciousness—Topiramate—migraine	5.9e-05	0.000741	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—TNF—migraine	5.89e-05	0.00146	CbGpPWpGaD
Aprepitant—Insomnia—Gabapentin—migraine	5.89e-05	0.00074	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—EDNRA—migraine	5.88e-05	0.00145	CbGpPWpGaD
Aprepitant—Cough—Topiramate—migraine	5.86e-05	0.000736	CcSEcCtD
Aprepitant—Paraesthesia—Gabapentin—migraine	5.85e-05	0.000734	CcSEcCtD
Aprepitant—Convulsion—Topiramate—migraine	5.81e-05	0.00073	CcSEcCtD
Aprepitant—Dyspnoea—Gabapentin—migraine	5.8e-05	0.000729	CcSEcCtD
Aprepitant—Hypertension—Topiramate—migraine	5.79e-05	0.000728	CcSEcCtD
Aprepitant—Somnolence—Gabapentin—migraine	5.79e-05	0.000727	CcSEcCtD
Aprepitant—Hypersensitivity—Valproic Acid—migraine	5.79e-05	0.000727	CcSEcCtD
Aprepitant—Feeling abnormal—Timolol—migraine	5.76e-05	0.000724	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—NOTCH3—migraine	5.73e-05	0.00142	CbGpPWpGaD
Aprepitant—Dyspepsia—Gabapentin—migraine	5.73e-05	0.00072	CcSEcCtD
Aprepitant—Gastrointestinal pain—Timolol—migraine	5.72e-05	0.000718	CcSEcCtD
Aprepitant—Chest pain—Topiramate—migraine	5.71e-05	0.000718	CcSEcCtD
Aprepitant—Myalgia—Topiramate—migraine	5.71e-05	0.000718	CcSEcCtD
Aprepitant—Arthralgia—Topiramate—migraine	5.71e-05	0.000718	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—HTR1A—migraine	5.7e-05	0.00141	CbGpPWpGaD
Aprepitant—Anxiety—Topiramate—migraine	5.69e-05	0.000715	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	5.67e-05	0.000713	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—CALCA—migraine	5.66e-05	0.0014	CbGpPWpGaD
Aprepitant—Decreased appetite—Gabapentin—migraine	5.66e-05	0.000711	CcSEcCtD
Aprepitant—Discomfort—Topiramate—migraine	5.64e-05	0.000709	CcSEcCtD
Aprepitant—Asthenia—Valproic Acid—migraine	5.63e-05	0.000708	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Gabapentin—migraine	5.62e-05	0.000706	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—TAC1—migraine	5.62e-05	0.00139	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—NPS—migraine	5.62e-05	0.00139	CbGpPWpGaD
Aprepitant—Fatigue—Gabapentin—migraine	5.61e-05	0.000705	CcSEcCtD
Aprepitant—Dry mouth—Topiramate—migraine	5.59e-05	0.000702	CcSEcCtD
Aprepitant—Constipation—Gabapentin—migraine	5.57e-05	0.000699	CcSEcCtD
Aprepitant—Pain—Gabapentin—migraine	5.57e-05	0.000699	CcSEcCtD
Aprepitant—Pruritus—Valproic Acid—migraine	5.56e-05	0.000698	CcSEcCtD
Aprepitant—Urticaria—Timolol—migraine	5.55e-05	0.000698	CcSEcCtD
Aprepitant—Abdominal pain—Timolol—migraine	5.53e-05	0.000694	CcSEcCtD
Aprepitant—Body temperature increased—Timolol—migraine	5.53e-05	0.000694	CcSEcCtD
Aprepitant—Confusional state—Topiramate—migraine	5.52e-05	0.000694	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—HTR2C—migraine	5.51e-05	0.00136	CbGpPWpGaD
Aprepitant—Oedema—Topiramate—migraine	5.48e-05	0.000688	CcSEcCtD
Aprepitant—Infection—Topiramate—migraine	5.44e-05	0.000684	CcSEcCtD
Aprepitant—Shock—Topiramate—migraine	5.39e-05	0.000677	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—HTR1B—migraine	5.38e-05	0.00133	CbGpPWpGaD
Aprepitant—Diarrhoea—Valproic Acid—migraine	5.37e-05	0.000675	CcSEcCtD
Aprepitant—Nervous system disorder—Topiramate—migraine	5.37e-05	0.000675	CcSEcCtD
Aprepitant—Feeling abnormal—Gabapentin—migraine	5.36e-05	0.000674	CcSEcCtD
Aprepitant—Thrombocytopenia—Topiramate—migraine	5.36e-05	0.000674	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—EDNRA—migraine	5.36e-05	0.00132	CbGpPWpGaD
Aprepitant—Tachycardia—Topiramate—migraine	5.35e-05	0.000672	CcSEcCtD
Aprepitant—Gastrointestinal pain—Gabapentin—migraine	5.32e-05	0.000669	CcSEcCtD
Aprepitant—Skin disorder—Topiramate—migraine	5.32e-05	0.000668	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—HTR7—migraine	5.3e-05	0.00131	CbGpPWpGaD
Aprepitant—Hyperhidrosis—Topiramate—migraine	5.29e-05	0.000665	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—HTR1D—migraine	5.25e-05	0.0013	CbGpPWpGaD
Aprepitant—Anorexia—Topiramate—migraine	5.22e-05	0.000656	CcSEcCtD
Aprepitant—Dizziness—Valproic Acid—migraine	5.19e-05	0.000652	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—HTR1A—migraine	5.18e-05	0.00128	CbGpPWpGaD
Aprepitant—Urticaria—Gabapentin—migraine	5.17e-05	0.00065	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—CALCA—migraine	5.16e-05	0.00127	CbGpPWpGaD
Aprepitant—Hypersensitivity—Timolol—migraine	5.15e-05	0.000647	CcSEcCtD
Aprepitant—Abdominal pain—Gabapentin—migraine	5.15e-05	0.000646	CcSEcCtD
Aprepitant—Body temperature increased—Gabapentin—migraine	5.15e-05	0.000646	CcSEcCtD
Aprepitant—Hypotension—Topiramate—migraine	5.12e-05	0.000643	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—TAC1—migraine	5.1e-05	0.00126	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—NPS—migraine	5.1e-05	0.00126	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	5.05e-05	0.00125	CbGpPWpGaD
Aprepitant—Asthenia—Timolol—migraine	5.02e-05	0.00063	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—HTR2C—migraine	5e-05	0.00124	CbGpPWpGaD
Aprepitant—Vomiting—Valproic Acid—migraine	4.99e-05	0.000627	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Topiramate—migraine	4.99e-05	0.000627	CcSEcCtD
Aprepitant—Insomnia—Topiramate—migraine	4.95e-05	0.000622	CcSEcCtD
Aprepitant—Rash—Valproic Acid—migraine	4.95e-05	0.000622	CcSEcCtD
Aprepitant—Dermatitis—Valproic Acid—migraine	4.95e-05	0.000621	CcSEcCtD
Aprepitant—Pruritus—Timolol—migraine	4.95e-05	0.000621	CcSEcCtD
Aprepitant—Headache—Valproic Acid—migraine	4.92e-05	0.000618	CcSEcCtD
Aprepitant—Paraesthesia—Topiramate—migraine	4.92e-05	0.000618	CcSEcCtD
Aprepitant—Dyspnoea—Topiramate—migraine	4.88e-05	0.000613	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—HTR2B—migraine	4.88e-05	0.00121	CbGpPWpGaD
Aprepitant—Somnolence—Topiramate—migraine	4.87e-05	0.000612	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—EDNRA—migraine	4.86e-05	0.0012	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—HTR7—migraine	4.82e-05	0.00119	CbGpPWpGaD
Aprepitant—Dyspepsia—Topiramate—migraine	4.82e-05	0.000606	CcSEcCtD
Aprepitant—Hypersensitivity—Gabapentin—migraine	4.8e-05	0.000603	CcSEcCtD
Aprepitant—Diarrhoea—Timolol—migraine	4.78e-05	0.000601	CcSEcCtD
Aprepitant—Decreased appetite—Topiramate—migraine	4.76e-05	0.000598	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Topiramate—migraine	4.73e-05	0.000594	CcSEcCtD
Aprepitant—Fatigue—Topiramate—migraine	4.72e-05	0.000593	CcSEcCtD
Aprepitant—Constipation—Topiramate—migraine	4.68e-05	0.000588	CcSEcCtD
Aprepitant—Pain—Topiramate—migraine	4.68e-05	0.000588	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—CALCA—migraine	4.68e-05	0.00116	CbGpPWpGaD
Aprepitant—Asthenia—Gabapentin—migraine	4.67e-05	0.000587	CcSEcCtD
Aprepitant—Nausea—Valproic Acid—migraine	4.66e-05	0.000586	CcSEcCtD
Aprepitant—Dizziness—Timolol—migraine	4.62e-05	0.000581	CcSEcCtD
Aprepitant—Pruritus—Gabapentin—migraine	4.61e-05	0.000579	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—TGFBR2—migraine	4.56e-05	0.00113	CbGpPWpGaD
Aprepitant—Feeling abnormal—Topiramate—migraine	4.51e-05	0.000567	CcSEcCtD
Aprepitant—Gastrointestinal pain—Topiramate—migraine	4.48e-05	0.000563	CcSEcCtD
Aprepitant—Diarrhoea—Gabapentin—migraine	4.45e-05	0.00056	CcSEcCtD
Aprepitant—Vomiting—Timolol—migraine	4.44e-05	0.000558	CcSEcCtD
Aprepitant—Rash—Timolol—migraine	4.41e-05	0.000554	CcSEcCtD
Aprepitant—Dermatitis—Timolol—migraine	4.4e-05	0.000553	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—HTR7—migraine	4.38e-05	0.00108	CbGpPWpGaD
Aprepitant—Headache—Timolol—migraine	4.38e-05	0.00055	CcSEcCtD
Aprepitant—Urticaria—Topiramate—migraine	4.35e-05	0.000547	CcSEcCtD
Aprepitant—Body temperature increased—Topiramate—migraine	4.33e-05	0.000544	CcSEcCtD
Aprepitant—Abdominal pain—Topiramate—migraine	4.33e-05	0.000544	CcSEcCtD
Aprepitant—Dizziness—Gabapentin—migraine	4.3e-05	0.000541	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—LRP1—migraine	4.29e-05	0.00106	CbGpPWpGaD
Aprepitant—Nausea—Timolol—migraine	4.15e-05	0.000522	CcSEcCtD
Aprepitant—Vomiting—Gabapentin—migraine	4.14e-05	0.00052	CcSEcCtD
Aprepitant—Rash—Gabapentin—migraine	4.1e-05	0.000516	CcSEcCtD
Aprepitant—Dermatitis—Gabapentin—migraine	4.1e-05	0.000515	CcSEcCtD
Aprepitant—Headache—Gabapentin—migraine	4.08e-05	0.000512	CcSEcCtD
Aprepitant—Hypersensitivity—Topiramate—migraine	4.04e-05	0.000507	CcSEcCtD
Aprepitant—Asthenia—Topiramate—migraine	3.93e-05	0.000494	CcSEcCtD
Aprepitant—Pruritus—Topiramate—migraine	3.87e-05	0.000487	CcSEcCtD
Aprepitant—Nausea—Gabapentin—migraine	3.87e-05	0.000486	CcSEcCtD
Aprepitant—Diarrhoea—Topiramate—migraine	3.75e-05	0.000471	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—HTR2A—migraine	3.71e-05	0.000917	CbGpPWpGaD
Aprepitant—Dizziness—Topiramate—migraine	3.62e-05	0.000455	CcSEcCtD
Aprepitant—Vomiting—Topiramate—migraine	3.48e-05	0.000437	CcSEcCtD
Aprepitant—Rash—Topiramate—migraine	3.45e-05	0.000434	CcSEcCtD
Aprepitant—Dermatitis—Topiramate—migraine	3.45e-05	0.000433	CcSEcCtD
Aprepitant—Headache—Topiramate—migraine	3.43e-05	0.000431	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—HTR2A—migraine	3.38e-05	0.000835	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ESR1—migraine	3.29e-05	0.000814	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOTCH4—migraine	3.29e-05	0.000814	CbGpPWpGaD
Aprepitant—Nausea—Topiramate—migraine	3.25e-05	0.000409	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—HTR1B—migraine	3.18e-05	0.000785	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—HTR2A—migraine	3.07e-05	0.000758	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HTR1A—migraine	3.06e-05	0.000756	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PGR—migraine	3.01e-05	0.000745	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NPS—migraine	3.01e-05	0.000745	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TAC1—migraine	3.01e-05	0.000745	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HTR2C—migraine	2.95e-05	0.00073	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EDNRA—migraine	2.87e-05	0.00071	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOTCH3—migraine	2.8e-05	0.000692	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CALCA—migraine	2.77e-05	0.000684	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HTR7—migraine	2.59e-05	0.00064	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	2.45e-05	0.000605	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	2.45e-05	0.000605	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CACNA1A—migraine	2.35e-05	0.000581	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFBR2—migraine	2.23e-05	0.000551	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HTR2A—migraine	1.81e-05	0.000448	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CACNA1A—migraine	1.7e-05	0.00042	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ESR1—migraine	1.61e-05	0.000398	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CACNA1A—migraine	1.31e-05	0.000324	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CACNA1A—migraine	1.2e-05	0.000296	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CACNA1A—migraine	1.02e-05	0.000253	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CACNA1A—migraine	7.89e-06	0.000195	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—migraine	7.77e-06	0.000192	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—migraine	5.62e-06	0.000139	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—migraine	4.34e-06	0.000107	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—migraine	3.96e-06	9.79e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—migraine	3.38e-06	8.36e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—migraine	2.61e-06	6.45e-05	CbGpPWpGaD
